Screener
Medicinova MNOV Q4 2025 Annual earnings
Reported February 20, 2026 · After market close
Revenue$151.0KMiss by $739.0
EPS-$0.05Beat by $0.05
Revenue estimate$151.7K
EPS estimate-$0.10
Next report
Date not yet announcedVersus estimates
Revenue
Q3 2026$140.0KBeat by $90.0KQ2 2026$459.0KBeat by $384.0KQ1 2026$187.0KIn line
Q4 2025$151.0KMiss by $739.0
Q3 2025$123.3KQ2 2025$134.6KDiluted EPS
FAQ
- When did Medicinova report Q4 2025 earnings?
- Medicinova (MNOV) reported Q4 2025 earnings on February 20, 2026 after market close.
- What were Medicinova's Q4 2025 revenue and EPS?
- Medicinova reported revenue of $151.0K and eps of $-0.05 for Q4 2025.
- Did Medicinova beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $151.7K by $739.0. EPS beat the consensus estimate of $-0.10 by $0.04.
- How did Medicinova's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 16.7% from $-0.06.
- Where can I find Medicinova's Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-060232) and the 10-K periodic report (0001193125-26-100432) directly on SEC EDGAR. The filing index links above go to sec.gov.
